ArticleJournal of diabetes science and technology2026
Multisystem Outcomes of GLP-1 Receptor Agonists Versus Active Comparators in Type 2 Diabetes: A Multicenter Target Trial Emulation.
Rohit Vashisht et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.